Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study
- PMID: 12789681
- DOI: 10.1002/gps.859
Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study
Similar articles
-
Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.Dement Geriatr Cogn Disord. 2009;27(3):232-9. doi: 10.1159/000203887. Epub 2009 Feb 25. Dement Geriatr Cogn Disord. 2009. PMID: 19246907 Clinical Trial.
-
The long-term efficacy and tolerability of donepezil in patients with vascular dementia.Int J Geriatr Psychiatry. 2010 Mar;25(3):305-13. doi: 10.1002/gps.2340. Int J Geriatr Psychiatry. 2010. PMID: 19623601 Clinical Trial.
-
Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.Int J Geriatr Psychiatry. 2007 Aug;22(8):806-12. doi: 10.1002/gps.1746. Int J Geriatr Psychiatry. 2007. PMID: 17199235 Clinical Trial.
-
Donepezil for Alzheimer's disease.Expert Rev Neurother. 2007 Oct;7(10):1243-9. doi: 10.1586/14737175.7.10.1243. Expert Rev Neurother. 2007. PMID: 17939763 Review.
-
Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.Int J Geriatr Psychiatry. 2004 Jun;19(6):509-15. doi: 10.1002/gps.1077. Int J Geriatr Psychiatry. 2004. PMID: 15211527 Review.
Cited by
-
Donepezil for dementia in people with Down syndrome.Cochrane Database Syst Rev. 2009 Jan 21;2009(1):CD007178. doi: 10.1002/14651858.CD007178.pub2. Cochrane Database Syst Rev. 2009. PMID: 19160328 Free PMC article.
-
Pharmacological management of behavioral and psychiatric symptoms in older adults with intellectual disability.Drugs Aging. 2015 Feb;32(2):95-102. doi: 10.1007/s40266-014-0236-7. Drugs Aging. 2015. PMID: 25573538 Review.
-
A meta-analysis and systematic review of interventions to prevent or treat cognitive decline related to Alzheimer's disease in adults with Down syndrome.Alzheimers Dement. 2025 Jul;21(7):e70471. doi: 10.1002/alz.70471. Alzheimers Dement. 2025. PMID: 40709486 Free PMC article. Review.
-
Cholinergic System Structure and Function Changes in Individuals with Down Syndrome During the Development of Alzheimer's Disease.Curr Top Behav Neurosci. 2025;69:49-78. doi: 10.1007/7854_2024_523. Curr Top Behav Neurosci. 2025. PMID: 39485646 Review.
-
Cognitive Rehabilitation of Dementia in Adults with Down Syndrome: A Review of Non-Pharmacological Interventions.Dement Geriatr Cogn Dis Extra. 2015 Sep 18;5(3):330-40. doi: 10.1159/000438858. eCollection 2015 Sep-Dec. Dement Geriatr Cogn Dis Extra. 2015. PMID: 26483832 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical